Company Information

LASA SUPERGENERICS LTD.

NSE : LASABSE : 540702ISIN CODE : INE670X01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE25.58-0.2 (-0.78 %)
PREV CLOSE ( ) 25.78
OPEN PRICE ( ) 25.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 13336
TODAY'S LOW / HIGH ( )25.26 26.42
52 WK LOW / HIGH ( )20.1 40.95
NSE25.700.05 (+0.19 %)
PREV CLOSE( ) 25.65
OPEN PRICE ( ) 25.95
BID PRICE (QTY) 25.70 (1408)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 55708
TODAY'S LOW / HIGH( ) 25.10 26.20
52 WK LOW / HIGH ( )20.6 41.2
ChairmanOmkar Pravin Herlekar
Managing DirectorOmkar Pravin Herlekar
Company SecretaryMitti Jain
Independent Non-Executive DirectorHardesh Raja Tolani
Ajay Sukhwani
Ekta Avtar Gurnasinghani
Manali Bhagtani
Whole Time DirectorShivanand Gajanan Hegde
Incorporation Year : 11-03 2016

Registered Office :

Address : C-4, C-4/1, M I D C,Lote Parshuram Industrial Area,Tal- Khed Ratnagiri Dist,
Maharashtra-415722 .

Phone : 02145 232101/232202

Email :  info@lasalabs.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.